Welcome!

News Feed Item

US Personalized Cancer Genome Sequencing Market Outlook 2018

NEW YORK, March 18, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

US Personalized Cancer Genome Sequencing Market Outlook 2018
http://www.reportlinker.com/p02048459/US-Personalized-Cancer-Genome-Sequencing-Market-Outlook-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics

The whole genome sequencing technology, over the past decade, has developed at an unprecedented rate. There has been a rapid progression from targeted gene sequencing to targeted whole genome sequencing coupled with bioinformatics based sequencing platforms to analyze the data and thereby impart personalized treatment to individuals. The Whole Genome Sequencing has proved to be a key to new breakthrough in fighting against cancer. The explosion of genomic data into personalized treatment of cancer is due to the development of new methods, and the exponential decline in cost of whole genome sequencing.

Our report entitled "US Personalized Cancer Genome Sequencing Market Outlook 2018" entails detailed study of current and future cancer prevalence and incidences across US. In addition, it provides an insight about the leading states with cancer incidences. Also covered is age wise statistics for cancer and comprehensive figures for cancer in males and females. Further, we have provided potential states for whole genome sequencing to help market players gauge maximum opportunity for growth. Besides, the report also provides potential customer base and the market's growth potential for personalized cancer WGS till 2018.

The said advanced technology has potential to revolutionize the field of medicine. We have closely monitored the regulatory landscape related to sequencing which requires consideration of the authorities over genome based tests. It has been observed that whole genome sequencing services have been concurrently regulated by FDA, CDC and CMS. Further, we have also discussed the various constraints faced by the industry players with suitable suggestions to overcome them. Apart from this, a major hurdle is to persuade health insurers to reimburse for the cost of sequencing the genomes of individual.

The report analyzes the competitive landscape of the market by properly analyzing the business, services and activities of the companies such as Illumina, Complete Genomics, and Ambry Genetics. It also provides the competitive benchmarking, taking into account key information such as market value, revenues, risk score etc., along with the strengths and weaknesses of each player. Overall, the report is a complete source of knowledge and statistics for clients who want to get an in-depth understanding of the market.
1. Analyst View
2. Research Methodology
3. Genome Sequencing: An Introduction
4. Cancer Statistics by Demographics
4.1 Prevalence, Incidences, and Mortality (2010-2018)
4.2 Leading States by Incidence
4.3 Leading Cancers by Incidence
4.3.1 Male Cancer Incidences
4.3.2 Female Cancer Incidences
4.3.3 Age-Group
5. US Personalized Cancer WGS Potential Market to 2018
6. US Personalized Cancer WGS: Current and Future Market Analysis
7. Regulatory Insights
7.1 Clinical Laboratory Improvement Amendments (CLIA) Accreditation
7.2 CAP Accreditation
8. Market Constraints
9. Competitive Assessment
9.1 Illumina
9.1.1 Business Overview
9.1.2 Key Information
9.1.3 Strengths and Weaknesses
9.2 Complete Genomics
9.2.1 Business Overview
9.2.2 Key Information
9.2.3 Strengths and Weaknesses
9.3 Beckman Coulter Genomics
9.3.1 Business Overview
9.3.2 Key Information
9.3.3 Strengths and Weaknesses
9.4 Expression Analysis
9.4.1 Business Overview
9.4.2 Key Information
9.4.3 Strengths and Weaknesses
9.5 EdgeBio
9.5.1 Business Overview
9.5.2 Key Information
9.5.3 Strengths and Weaknesses
9.6 Foundation Medicine
9.6.1 Business Overview
9.6.2 Key Information
9.6.3 Strengths and Weaknesses
9.7 SeqWright
9.7.1 Business Overview
9.7.2 Key Information
9.7.3 Strengths and Weaknesses
9.8 Ambry Genetics
9.8.1 Business Overview
9.8.2 Key Information
9.8.3 Strengths and Weaknesses
9.9 BGI Americas Corporation
9.9.1 Business Overview
9.9.2 Key Information
9.9.3 Strengths and Weaknesses
9.10 Cofactor Genomics
9.10.1 Business Overview
9.10.2 Key Information
9.10.3 Strengths and Weaknesses

List of Figures:

Figure 3-1: Schematic Diagram of Sequencing used for Human Genome Project
Figure 3-2: Long-range Sequence Assembly in Whole Genome Shotgun Sequencing
Figure 4-1: Cancer Prevalence (Million), 2010-2018
Figure 4-2: Cancer Incidences (Million), 2010-2018
Figure 4-3: Cancer Mortality ('000), 2010-2018
Figure 4-4: Incidences by Type of Cancer (%), 2014
Figure 4-5: Cancer Incidences by Age Group (%), 2010
Figure 5-1: Number of People earning > US$ 100K (2009-2012)
Figure 5-2: Potential Customers for Personalized Cancer WGS Market (Billion), 2013-2018
Figure 5-3: Potential Customers for Personalized Cancer WGS Market by Age-Group (%), 2014
Figure 5-4: Potential Market for Personalized Cancer WGS (Billion US$), 2013-2018
Figure 6-1: Tapped and Untapped Personalized Cancer WGS Market (%), 2014
Figure 6-2: Personalized Cancer WGS Market (Million US$), 2013-2018

List of Tables:

Table 4-1: Top Ten States with Highest Cancer Incidences ('000), 2014
Table 4-2: Top Ten Cancer Incidences in Males (2014)
Table 4-3: Top Ten Cancer Incidences in Females (2014)
Table 5-1: Top Ten States with Households earning > US$ 100K (2012)
Table 5-2: Key Demographics and Potential Customers for Personalized Cancer WGS Market (2014)
Table 5-3: Potential States for Personalized Cancer Whole Genome Sequencing
Table 9-1: Illumina - Key information
Table 9-2: Complete Genomics - Key Information
Table 9-3: Beckman Coulter Genomics - Key Information
Table 9-4: Expression Analysis - Key Information
Table 9-5: Edge Bio - Key Information
Table 9-6: Foundation Medicine - Key Information
Table 9-7: SeqWright - Key Information
Table 9-8: Ambry Genetics - Key Information
Table 9-9: BGI Americas Corporation - Key Information
Table 9-10: Cofactor Genomics - Key Information

To order this report: US Personalized Cancer Genome Sequencing Market Outlook 2018
http://www.reportlinker.com/p02048459/US-Personalized-Cancer-Genome-Sequencing-Market-Outlook-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Join IBM November 1 at 21st Cloud Expo at the Santa Clara Convention Center in Santa Clara, CA, and learn how IBM Watson can bring cognitive services and AI to intelligent, unmanned systems. Cognitive analysis impacts today’s systems with unparalleled ability that were previously available only to manned, back-end operations. Thanks to cloud processing, IBM Watson can bring cognitive services and AI to intelligent, unmanned systems. Imagine a robot vacuum that becomes your personal assistant tha...
Data scientists must access high-performance computing resources across a wide-area network. To achieve cloud-based HPC visualization, researchers must transfer datasets and visualization results efficiently. HPC clusters now compute GPU-accelerated visualization in the cloud cluster. To efficiently display results remotely, a high-performance, low-latency protocol transfers the display from the cluster to a remote desktop. Further, tools to easily mount remote datasets and efficiently transfer...
SYS-CON Events announced today that TidalScale will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. TidalScale is the leading provider of Software-Defined Servers that bring flexibility to modern data centers by right-sizing servers on the fly to fit any data set or workload. TidalScale’s award-winning inverse hypervisor technology combines multiple commodity servers (including their ass...
As hybrid cloud becomes the de-facto standard mode of operation for most enterprises, new challenges arise on how to efficiently and economically share data across environments. In his session at 21st Cloud Expo, Dr. Allon Cohen, VP of Product at Elastifile, will explore new techniques and best practices that help enterprise IT benefit from the advantages of hybrid cloud environments by enabling data availability for both legacy enterprise and cloud-native mission critical applications. By rev...
Infoblox delivers Actionable Network Intelligence to enterprise, government, and service provider customers around the world. They are the industry leader in DNS, DHCP, and IP address management, the category known as DDI. We empower thousands of organizations to control and secure their networks from the core-enabling them to increase efficiency and visibility, improve customer service, and meet compliance requirements.
In his session at 21st Cloud Expo, Michael Burley, a Senior Business Development Executive in IT Services at NetApp, will describe how NetApp designed a three-year program of work to migrate 25PB of a major telco's enterprise data to a new STaaS platform, and then secured a long-term contract to manage and operate the platform. This significant program blended the best of NetApp’s solutions and services capabilities to enable this telco’s successful adoption of private cloud storage and launchi...
Cloud Expo, Inc. has announced today that Andi Mann and Aruna Ravichandran have been named Co-Chairs of @DevOpsSummit at Cloud Expo Silicon Valley which will take place Oct. 31-Nov. 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. "DevOps is at the intersection of technology and business-optimizing tools, organizations and processes to bring measurable improvements in productivity and profitability," said Aruna Ravichandran, vice president, DevOps product and solutions marketing...
With major technology companies and startups seriously embracing Cloud strategies, now is the perfect time to attend 21st Cloud Expo October 31 - November 2, 2017, at the Santa Clara Convention Center, CA, and June 12-14, 2018, at the Javits Center in New York City, NY, and learn what is going on, contribute to the discussions, and ensure that your enterprise is on the right path to Digital Transformation.
SYS-CON Events announced today that N3N will exhibit at SYS-CON's @ThingsExpo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. N3N’s solutions increase the effectiveness of operations and control centers, increase the value of IoT investments, and facilitate real-time operational decision making. N3N enables operations teams with a four dimensional digital “big board” that consolidates real-time live video feeds alongside IoT sensor data a...
Amazon is pursuing new markets and disrupting industries at an incredible pace. Almost every industry seems to be in its crosshairs. Companies and industries that once thought they were safe are now worried about being “Amazoned.”. The new watch word should be “Be afraid. Be very afraid.” In his session 21st Cloud Expo, Chris Kocher, a co-founder of Grey Heron, will address questions such as: What new areas is Amazon disrupting? How are they doing this? Where are they likely to go? What are th...
In his Opening Keynote at 21st Cloud Expo, John Considine, General Manager of IBM Cloud Infrastructure, will lead you through the exciting evolution of the cloud. He'll look at this major disruption from the perspective of technology, business models, and what this means for enterprises of all sizes. John Considine is General Manager of Cloud Infrastructure Services at IBM. In that role he is responsible for leading IBM’s public cloud infrastructure including strategy, development, and offering ...
In the fast-paced advances and popularity in cloud technology, one of the most critical factors revolves around concerns for security of your critical data. How to assure both your company and your customers they can confidently trust and utilize your cloud environment is most often top on the list. There is a method to evaluating and providing security that exceeds conventional modes of protecting data both within the cloud as well externally on mobile and other devices. With the public failure...
Digital transformation is changing the face of business. The IDC predicts that enterprises will commit to a massive new scale of digital transformation, to stake out leadership positions in the "digital transformation economy." Accordingly, attendees at the upcoming Cloud Expo | @ThingsExpo at the Santa Clara Convention Center in Santa Clara, CA, Oct 31-Nov 2, will find fresh new content in a new track called Enterprise Cloud & Digital Transformation.
SYS-CON Events announced today that NetApp has been named “Bronze Sponsor” of SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. NetApp is the data authority for hybrid cloud. NetApp provides a full range of hybrid cloud data services that simplify management of applications and data across cloud and on-premises environments to accelerate digital transformation. Together with their partners, NetApp emp...
The dynamic nature of the cloud means that change is a constant when it comes to modern cloud-based infrastructure. Delivering modern applications to end users, therefore, is a constantly shifting challenge. Delivery automation helps IT Ops teams ensure that apps are providing an optimal end user experience over hybrid-cloud and multi-cloud environments, no matter what the current state of the infrastructure is. To employ a delivery automation strategy that reflects your business rules, making r...